| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.851 | 0.002 | 0.851 | Histamine H1 receptor antagonist | 0.535 0.004 CID_124087 | ||
| 0.672 | 0.004 | 0.672 | Antihistaminic | 0.406 0.006 CID_124087 | ||
| 0.668 | 0.004 | 0.668 | Histamine antagonist | 0.403 0.005 CID_124087 | ||
| 0.537 | 0.039 | 0.537 | Analgesic | 0.385 0.091 CID_124087 | ||
| 0.45 | 0.016 | 0.494 | Anticonvulsant | 0.494 0.012 CID_124087 | CID_124087 | |
| 0.432 | 0.039 | 0.736 | 5 Hydroxytryptamine release stimulant | 0.736 0.005 CID_124087 | CID_124087 | |
| 0.403 | 0.064 | 0.403 | Antiobesity | 0.358 0.083 CID_124087 | ||
| 0.32 | 0.031 | 0.358 | Platelet aggregation inhibitor | 0.358 0.024 CID_124087 | CID_124087 | |
| 0.289 | 0.016 | 0.289 | Antipruritic | 0.237 0.029 CID_124087 | ||
| 0.31 | 0.066 | 0.31 | Spasmolytic | 0.24 0.096 CID_124087 | ||
| 0.248 | 0.029 | 0.248 | Cholinergic | 0.143 0.082 CID_124087 | ||
| 0.223 | 0.006 | 0.223 | Pregnane X receptor agonist | 0.208 0.009 CID_124087 | ||
| 0.318 | 0.104 | 0.459 | GABA C receptor rho-3 antagonist | 0.459 0.038 CID_124087 | CID_124087 | |
| 0.245 | 0.034 | 0.245 | Amyloid beta precursor protein antagonist | |||
| 0.201 | 0.014 | 0.201 | Acetylcholine agonist | 0.089 0.056 CID_124087 | ||
| 0.217 | 0.035 | 0.217 | Acetylcholine M1 receptor antagonist | 0.209 0.038 CID_124087 | ||
| 0.188 | 0.007 | 0.188 | Acetylcholine muscarinic agonist | |||
| 0.21 | 0.031 | 0.21 | Insulin secretagoues | |||
| 0.274 | 0.111 | 0.37 | Vasodilator, peripheral | 0.37 0.066 CID_124087 | CID_124087 | |
| 0.185 | 0.023 | 0.227 | MAP3K9 inhibitor | 0.227 0.008 CID_124087 | CID_124087 | |
| 0.181 | 0.02 | 0.46 | 5 Hydroxytryptamine 2C antagonist | 0.46 0.005 CID_124087 | CID_124087 | |
| 0.322 | 0.171 | 0.412 | Caspase 9 stimulant | 0.412 0.104 CID_124087 | CID_124087 | |
| 0.179 | 0.031 | 0.43 | 5 Hydroxytryptamine 2B antagonist | 0.43 0.007 CID_124087 | CID_124087 | |
| 0.212 | 0.066 | 0.259 | Neurotrophic factor enhancer | 0.259 0.034 CID_124087 | CID_124087 | |
| 0.151 | 0.007 | 0.151 | Acetylcholine M1 receptor agonist | |||
| 0.158 | 0.015 | 0.158 | Acetylcholine M3 receptor agonist | |||
| 0.169 | 0.036 | 0.195 | Platelet activating factor antagonist | 0.195 0.028 CID_124087 | CID_124087 | |
| 0.135 | 0.005 | 0.165 | Farnesyltransferase inhibitor | 0.165 0.004 CID_124087 | CID_124087 | |
| 0.268 | 0.142 | 0.294 | Histamine release inhibitor | 0.294 0.127 CID_124087 | CID_124087 | |
| 0.199 | 0.075 | 0.199 | Anesthetic general | 0.175 0.09 CID_124087 | ||
| 0.135 | 0.013 | 0.195 | Acetylcholine M4 receptor antagonist | 0.195 0.006 CID_124087 | CID_124087 | |
| 0.216 | 0.096 | 0.249 | Tumour necrosis factor alpha release inhibitor | 0.249 0.076 CID_124087 | CID_124087 | |
| 0.121 | 0.01 | 0.121 | Acetylcholine M5 receptor agonist | |||
| 0.147 | 0.036 | 0.189 | Interleukin 8 antagonist | 0.189 0.016 CID_124087 | CID_124087 | |
| 0.148 | 0.039 | 0.375 | Alpha 2b adrenoreceptor antagonist | 0.375 0.005 CID_124087 | CID_124087 | |
| 0.127 | 0.018 | 0.238 | Dopamine D1 antagonist | 0.238 0.008 CID_124087 | CID_124087 | |
| 0.129 | 0.023 | 0.137 | Lanosterol 14 alpha demethylase inhibitor | 0.137 0.017 CID_124087 | CID_124087 | |
| 0.119 | 0.016 | 0.128 | Benzodiazepine agonist | 0.128 0.013 CID_124087 | CID_124087 | |
| 0.162 | 0.059 | 0.263 | GABA C receptor rho-2 antagonist | 0.263 0.009 CID_124087 | CID_124087 | |
| 0.121 | 0.02 | 0.121 | Histamine H2 receptor antagonist | |||
| 0.146 | 0.046 | 0.391 | 5 Hydroxytryptamine 2 antagonist | 0.391 0.01 CID_124087 | CID_124087 | |
| 0.228 | 0.128 | 0.413 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.413 0.019 CID_124087 | CID_124087 | |
| 0.115 | 0.018 | 0.115 | Calcium channel L-type blocker | |||
| 0.2 | 0.104 | 0.312 | MAP-kinase-activated kinase 5 inhibitor | 0.312 0.024 CID_124087 | CID_124087 | |
| 0.194 | 0.098 | 0.319 | Cyclic AMP phosphodiesterase inhibitor | 0.319 0.035 CID_124087 | CID_124087 | |
| 0.1 | 0.004 | 0.1 | Acetylcholine M4 receptor agonist | |||
| 0.118 | 0.024 | 0.314 | 5 Hydroxytryptamine 1F antagonist | 0.314 0.005 CID_124087 | CID_124087 | |
| 0.234 | 0.14 | 0.234 | Antithrombotic | 0.228 0.146 CID_124087 | ||
| 0.106 | 0.014 | 0.178 | 5 Hydroxytryptamine 5A antagonist | 0.178 0.005 CID_124087 | CID_124087 | |
| 0.1 | 0.009 | 0.1 | Potassium channel intermediate-conductance Ca-activated blocker | 0.056 0.052 CID_124087 | ||
| 0.116 | 0.026 | 0.126 | Bromodomain-containing protein 2 inhibitor | 0.126 0.019 CID_124087 | CID_124087 | |
| 0.104 | 0.014 | 0.19 | 5 Hydroxytryptamine 5 antagonist | 0.19 0.005 CID_124087 | CID_124087 | |
| 0.203 | 0.114 | 0.203 | Neuropeptide Y2 antagonist | 0.189 0.14 CID_124087 | ||
| 0.285 | 0.197 | 0.285 | MAP kinase 1 inhibitor | |||
| 0.146 | 0.061 | 0.195 | Interleukin 1 antagonist | 0.195 0.035 CID_124087 | CID_124087 | |
| 0.105 | 0.022 | 0.105 | Amidase inhibitor | |||
| 0.088 | 0.01 | 0.088 | Acetylcholine M2 receptor agonist | |||
| 0.128 | 0.05 | 0.165 | GABA receptor agonist | 0.165 0.029 CID_124087 | CID_124087 | |
| 0.102 | 0.027 | 0.191 | Dopamine agonist | 0.191 0.01 CID_124087 | CID_124087 | |
| 0.115 | 0.04 | 0.125 | Antineoplastic alkaloid | 0.125 0.035 CID_124087 | CID_124087 | |
| 0.12 | 0.048 | 0.132 | Acetylcholine release stimulant | 0.132 0.032 CID_124087 | CID_124087 | |
| 0.172 | 0.102 | 0.361 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.361 0.021 CID_124087 | CID_124087 | |
| 0.096 | 0.026 | 0.096 | Viral attachment inhibitor | 0.092 0.031 CID_124087 | ||
| 0.121 | 0.055 | 0.121 | Calcium channel (voltage-sensitive) blocker | |||
| 0.13 | 0.065 | 0.166 | Glutamate receptor antagonist | 0.166 0.041 CID_124087 | CID_124087 | |
| 0.072 | 0.01 | 0.072 | G protein-coupled receptor agonist | |||
| 0.077 | 0.014 | 0.077 | 5 Hydroxytryptamine 4 antagonist | 0.074 0.015 CID_124087 | ||
| 0.075 | 0.014 | 0.075 | Oleamide hydrolase inhibitor | |||
| 0.134 | 0.074 | 0.183 | Nav1.6 sodium channel blocker | 0.183 0.026 CID_124087 | CID_124087 | |
| 0.104 | 0.044 | 0.317 | 5 Hydroxytryptamine 2A antagonist | 0.317 0.01 CID_124087 | CID_124087 | |
| 0.085 | 0.027 | 0.085 | Acetylcholine M2 receptor antagonist | 0.06 0.045 CID_124087 | ||
| 0.132 | 0.075 | 0.132 | Calcium channel blocker | |||
| 0.121 | 0.066 | 0.121 | Acetylcholine muscarinic antagonist | 0.111 0.077 CID_124087 | ||
| 0.187 | 0.132 | 0.187 | Cardiotonic | |||
| 0.078 | 0.025 | 0.289 | Alpha 2 adrenoreceptor agonist | 0.289 0.004 CID_124087 | CID_124087 | |
| 0.063 | 0.01 | 0.063 | Benzodiazepine antagonist | 0.049 0.029 CID_124087 | ||
| 0.11 | 0.057 | 0.188 | Alpha 2c adrenoreceptor antagonist | 0.188 0.02 CID_124087 | CID_124087 | |
| 0.082 | 0.03 | 0.244 | 5 Hydroxytryptamine 7 antagonist | 0.244 0.008 CID_124087 | CID_124087 | |
| 0.171 | 0.12 | 0.286 | Potassium channel (Voltage-sensitive) blocker | 0.286 0.054 CID_124087 | CID_124087 | |
| 0.064 | 0.014 | 0.064 | Cholesterol esterase inhibitor | |||
| 0.059 | 0.008 | 0.059 | Glucose-dependent insulinotropic receptor agonist | |||
| 0.131 | 0.081 | 0.131 | Farnesoid X receptor antagonist | |||
| 0.115 | 0.068 | 0.42 | 5 Hydroxytryptamine antagonist | 0.42 0.01 CID_124087 | CID_124087 | |
| 0.202 | 0.155 | 0.202 | Nootropic | |||
| 0.071 | 0.026 | 0.071 | Calcium channel P-type blocker | |||
| 0.068 | 0.024 | 0.068 | Autotaxin inhibitor | |||
| 0.093 | 0.05 | 0.093 | Phosphodiesterase IV inhibitor | |||
| 0.111 | 0.069 | 0.111 | TRPA1 agonist | |||
| 0.117 | 0.077 | 0.141 | Cholinergic antagonist | 0.141 0.058 CID_124087 | CID_124087 | |
| 0.075 | 0.037 | 0.166 | 5 Hydroxytryptamine 1B antagonist | 0.166 0.011 CID_124087 | CID_124087 | |
| 0.078 | 0.039 | 0.286 | Alpha adrenoreceptor agonist | 0.286 0.005 CID_124087 | CID_124087 | |
| 0.058 | 0.021 | 0.156 | Histamine H4 receptor antagonist | 0.156 0.004 CID_124087 | CID_124087 | |
| 0.072 | 0.038 | 0.072 | Purinergic P2 antagonist | |||
| 0.09 | 0.056 | 0.168 | Histamine N-methyltransferase inhibitor | 0.168 0.009 CID_124087 | CID_124087 | |
| 0.175 | 0.142 | 0.176 | RNA-directed DNA polymerase inhibitor | 0.176 0.14 CID_124087 | CID_124087 | |
| 0.095 | 0.061 | 0.095 | Bile acid receptor antagonist | 0.089 0.075 CID_124087 | ||
| 0.076 | 0.043 | 0.14 | Glycine receptor agonist | 0.14 0.008 CID_124087 | CID_124087 | |
| 0.066 | 0.033 | 0.081 | Prolactin release inhibitor | 0.081 0.01 CID_124087 | CID_124087 | |
| 0.055 | 0.022 | 0.063 | Dopamine D5 antagonist | 0.063 0.018 CID_124087 | CID_124087 | |
| 0.084 | 0.052 | 0.093 | Transforming growth factor beta 3 antagonist | 0.093 0.033 CID_124087 | CID_124087 | |
| 0.106 | 0.074 | 0.132 | Nav1.5 sodium channel blocker | 0.132 0.041 CID_124087 | CID_124087 | |
| 0.051 | 0.02 | 0.051 | Glutamate (mGluR1a) antagonist | |||
| 0.106 | 0.075 | 0.147 | Interleukin 1b antagonist | 0.147 0.042 CID_124087 | CID_124087 | |
| 0.1 | 0.07 | 0.1 | Mediator release inhibitor | |||
| 0.054 | 0.024 | 0.104 | Dopamine D2 agonist | 0.104 0.01 CID_124087 | CID_124087 | |
| 0.109 | 0.08 | 0.135 | Acetylcholine antagonist | 0.135 0.059 CID_124087 | CID_124087 | |
| 0.087 | 0.058 | 0.289 | Alpha 2 adrenoreceptor antagonist | 0.289 0.009 CID_124087 | CID_124087 | |
| 0.036 | 0.01 | 0.036 | Purinergic P2Y12 antagonist | |||
| 0.245 | 0.219 | 0.245 | Cyclophilin D inhibitor | |||
| 0.051 | 0.027 | 0.247 | 5 Hydroxytryptamine 2C agonist | 0.247 0.004 CID_124087 | CID_124087 | |
| 0.057 | 0.033 | 0.086 | GABA A receptor antagonist | 0.086 0.02 CID_124087 | CID_124087 | |
| 0.214 | 0.192 | 0.324 | Calcium channel activator | 0.324 0.069 CID_124087 | CID_124087 | |
| 0.25 | 0.228 | 0.303 | 5 Hydroxytryptamine release inhibitor | 0.303 0.162 CID_124087 | CID_124087 | |
| 0.045 | 0.024 | 0.057 | Antidiuretic hormone antagonist | 0.057 0.02 CID_124087 | CID_124087 | |
| 0.151 | 0.13 | 0.259 | HERG channel blocker | 0.259 0.063 CID_124087 | CID_124087 | |
| 0.054 | 0.033 | 0.309 | 5 Hydroxytryptamine 2 agonist | 0.309 0.003 CID_124087 | CID_124087 | |
| 0.119 | 0.098 | 0.197 | Activin receptor-like kinase 2 inhibitor | 0.197 0.038 CID_124087 | CID_124087 | |
| 0.105 | 0.087 | 0.105 | Calcium channel N-type blocker | |||
| 0.156 | 0.138 | 0.156 | Platelet antagonist | |||
| 0.042 | 0.025 | 0.05 | Acid-sensing ion channel blocker | 0.05 0.017 CID_124087 | CID_124087 | |
| 0.046 | 0.029 | 0.046 | Histamine H3 receptor antagonist | |||
| 0.054 | 0.038 | 0.088 | GABA receptor antagonist | 0.088 0.019 CID_124087 | CID_124087 | |
| 0.054 | 0.038 | 0.105 | Lysine-specific demethylase 1A inhibitor | 0.105 0.006 CID_124087 | CID_124087 | |
| 0.067 | 0.051 | 0.067 | Elastase 1 inhibitor | |||
| 0.064 | 0.05 | 0.064 | Phosphodiesterase 4B inhibitor | |||
| 0.035 | 0.021 | 0.035 | ADAM10 endopeptidase inhibitor | |||
| 0.043 | 0.031 | 0.066 | Alpha 1L adrenoreceptor agonist | 0.066 0.006 CID_124087 | CID_124087 | |
| 0.039 | 0.027 | 0.253 | 5 Hydroxytryptamine 2B agonist | 0.253 0.002 CID_124087 | CID_124087 | |
| 0.034 | 0.024 | 0.034 | Benzodiazepine receptor peripheral-type antagonist | |||
| 0.024 | 0.015 | 0.024 | CC chemokine 8 receptor antagonist | |||
| 0.068 | 0.06 | 0.354 | Alpha 2a adrenoreceptor antagonist | 0.354 0.005 CID_124087 | CID_124087 | |
| 0.076 | 0.069 | 0.097 | Ca(v)2.2 blocker | 0.097 0.051 CID_124087 | CID_124087 | |
| 0.012 | 0.008 | 0.012 | Glucose-dependent insulinotropic receptor antagonist | |||
| 0.026 | 0.023 | 0.036 | Nicotinic alpha4beta2 receptor agonist | 0.036 0.011 CID_124087 | CID_124087 | |
| 0.035 | 0.032 | 0.035 | Vascular adhesion protein 1 inhibitor | |||
| 0.101 | 0.098 | 0.129 | Sphingosine 1-phosphate receptor 2 agonist | 0.129 0.043 CID_124087 | CID_124087 | |
| 0.051 | 0.049 | 0.122 | Dopamine D4 antagonist | 0.122 0.021 CID_124087 | CID_124087 | |
| 0.018 | 0.017 | 0.018 | Purinergic P2T antagonist | |||
| 0.041 | 0.04 | 0.041 | Glutamate (mGluR5) antagonist | |||
| 0.028 | 0.028 | 0.058 | Vasopressin 2 antagonist | 0.058 0.012 CID_124087 | CID_124087 | |
| 0.118 | 0.119 | 0.155 | NOS3 expression enhancer | 0.155 0.067 CID_124087 | CID_124087 | |
| 0.04 | 0.042 | 0.097 | Histamine H1 receptor agonist | 0.097 0.002 CID_124087 | CID_124087 | |
| 0.042 | 0.047 | 0.048 | Bromodomain-containing protein 3 inhibitor | 0.048 0.036 CID_124087 | CID_124087 | |
| 0.019 | 0.024 | 0.028 | Dopamine D1 agonist | 0.028 0.01 CID_124087 | CID_124087 | |
| 0.045 | 0.052 | 0.088 | Protein kinase C eta inhibitor | 0.088 0.02 CID_124087 | CID_124087 | |
| 0.037 | 0.044 | 0.063 | GABA B receptor antagonist | 0.063 0.011 CID_124087 | CID_124087 | |
| 0.06 | 0.068 | 0.118 | CXC chemokine receptor antagonist | 0.118 0.018 CID_124087 | CID_124087 | |
| 0.05 | 0.059 | 0.064 | Acetylcholine M5 receptor antagonist | 0.064 0.037 CID_124087 | CID_124087 | |
| 0.029 | 0.037 | 0.08 | 5 Hydroxytryptamine 3B antagonist | 0.08 0.007 CID_124087 | CID_124087 | |
| 0.012 | 0.023 | 0.021 | Nicotinic alpha4 receptor agonist | 0.021 0.006 CID_124087 | CID_124087 | |
| 0.057 | 0.068 | 0.188 | 5 Hydroxytryptamine 1 antagonist | 0.188 0.018 CID_124087 | CID_124087 | |
| 0.07 | 0.082 | 0.213 | Alpha adrenoreceptor antagonist | 0.213 0.026 CID_124087 | CID_124087 | |
| 0.034 | 0.047 | 0.076 | Phenylethanolamine N methyltransferase inhibitor | 0.076 0.004 CID_124087 | CID_124087 | |
| 0.077 | 0.091 | 0.098 | Sphingomyelinase inhibitor | 0.098 0.061 CID_124087 | CID_124087 | |
| 0.055 | 0.069 | 0.178 | Dopamine antagonist | 0.178 0.021 CID_124087 | CID_124087 | |
| 0.042 | 0.059 | 0.051 | Phosphodiesterase 4C inhibitor | 0.051 0.044 CID_124087 | CID_124087 | |
| 0.03 | 0.049 | 0.043 | Factor XIa inhibitor | 0.043 0.026 CID_124087 | CID_124087 | |
| 0.042 | 0.061 | 0.139 | 5 Hydroxytryptamine 3 antagonist | 0.139 0.01 CID_124087 | CID_124087 | |
| 0.05 | 0.071 | 0.098 | 5 Hydroxytryptamine 3 agonist | 0.098 0.016 CID_124087 | CID_124087 | |
| 0.037 | 0.06 | 0.075 | Dopamine D4 agonist | 0.075 0.021 CID_124087 | CID_124087 | |
| 0.046 | 0.069 | 0.15 | 5 Hydroxytryptamine 1A antagonist | 0.15 0.02 CID_124087 | CID_124087 | |
| 0.058 | 0.081 | 0.137 | Nicotinic alpha4beta2 receptor antagonist | 0.137 0.011 CID_124087 | CID_124087 | |
| 0.042 | 0.065 | 0.171 | 5 Hydroxytryptamine 6 antagonist | 0.171 0.005 CID_124087 | CID_124087 | |
| 0.149 | 0.174 | 0.196 | DNA damaging | 0.196 0.118 CID_124087 | CID_124087 | |
| 0.05 | 0.075 | 0.06 | Phosphodiesterase 1A inhibitor | 0.06 0.04 CID_124087 | CID_124087 | |
| 0.082 | 0.108 | 0.095 | Hedgehog signaling inhibitor | 0.095 0.073 CID_124087 | CID_124087 | |
| 0.072 | 0.099 | 0.098 | Topoisomerase I inhibitor | 0.098 0.072 CID_124087 | CID_124087 | |
| 0.12 | 0.147 | 0.339 | Psychostimulant | 0.339 0.034 CID_124087 | CID_124087 | |
| 0.02 | 0.049 | 0.031 | Purinergic P2Y14 antagonist | 0.031 0.02 CID_124087 | CID_124087 | |
| 0.155 | 0.184 | 0.318 | 5 Hydroxytryptamine 1E antagonist | 0.318 0.02 CID_124087 | CID_124087 | |
| 0.058 | 0.088 | 0.065 | MDM2 inhibitor | 0.065 0.056 CID_124087 | CID_124087 | |
| 0.021 | 0.051 | 0.075 | 5 Hydroxytryptamine 6 agonist | 0.075 0.003 CID_124087 | CID_124087 | |
| 0.067 | 0.097 | 0.09 | MAO A inhibitor | 0.09 0.071 CID_124087 | CID_124087 | |
| 0.082 | 0.113 | 0.18 | Protein kinase C gamma inhibitor | 0.18 0.019 CID_124087 | CID_124087 | |
| 0.044 | 0.076 | 0.318 | 5 Hydroxytryptamine agonist | 0.318 0.008 CID_124087 | CID_124087 | |
| 0.035 | 0.068 | 0.051 | Purinergic P2X4 antagonist | 0.051 0.023 CID_124087 | CID_124087 | |
| 0.039 | 0.076 | 0.099 | Dopamine D3 antagonist | 0.099 0.025 CID_124087 | CID_124087 | |
| 0.046 | 0.087 | 0.107 | Cyclin B3 inhibitor | 0.107 0.026 CID_124087 | CID_124087 | |
| 0.04 | 0.082 | 0.117 | Nicotinic alpha3beta2 receptor antagonist | 0.117 0.005 CID_124087 | CID_124087 | |
| 0.038 | 0.083 | 0.136 | Alpha 1a adrenoreceptor antagonist | 0.136 0.026 CID_124087 | CID_124087 | |
| 0.069 | 0.116 | 0.086 | Hematopoietic | 0.086 0.057 CID_124087 | CID_124087 | |
| 0.087 | 0.135 | 0.175 | Sodium channel blocker | 0.175 0.043 CID_124087 | CID_124087 | |
| 0.034 | 0.082 | 0.135 | Dopamine D2 antagonist | 0.135 0.024 CID_124087 | CID_124087 | |
| 0.048 | 0.096 | 0.127 | Protein kinase C alpha inhibitor | 0.127 0.014 CID_124087 | CID_124087 | |
| 0.044 | 0.093 | 0.072 | Potassium channel (Ca-activated) blocker | 0.072 0.024 CID_124087 | CID_124087 | |
| 0.041 | 0.091 | 0.096 | 5 Hydroxytryptamine 3A antagonist | 0.096 0.019 CID_124087 | CID_124087 | |
| 0.011 | 0.061 | 0.032 | Alpha 2b adrenoreceptor agonist | 0.032 0.004 CID_124087 | CID_124087 | |
| 0.009 | 0.059 | 0.038 | Alpha 2c adrenoreceptor agonist | 0.038 0.004 CID_124087 | CID_124087 | |
| 0.05 | 0.1 | 0.165 | MAP-kinase-activated kinase 2 inhibitor | 0.165 0.008 CID_124087 | CID_124087 | |
| 0.038 | 0.088 | 0.084 | 5 Hydroxytryptamine 1D antagonist | 0.084 0.029 CID_124087 | CID_124087 | |
| 0.057 | 0.11 | 0.177 | MAP-kinase-activated kinase inhibitor | 0.177 0.008 CID_124087 | CID_124087 | |
| 0.071 | 0.124 | 0.211 | GABA C receptor rho-1 antagonist | 0.211 0.007 CID_124087 | CID_124087 | |
| 0.096 | 0.151 | 0.341 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.341 0.028 CID_124087 | CID_124087 | |
| 0.055 | 0.111 | 0.121 | Antiadrenergic | 0.121 0.045 CID_124087 | CID_124087 | |
| 0.014 | 0.07 | 0.049 | Nicotinic alpha3beta4 receptor agonist | 0.049 0.005 CID_124087 | CID_124087 | |
| 0.053 | 0.111 | 0.117 | Adrenaline antagonist | 0.117 0.045 CID_124087 | CID_124087 | |
| 0.039 | 0.098 | 0.148 | Alpha 1 adrenoreceptor antagonist | 0.148 0.03 CID_124087 | CID_124087 | |
| 0.039 | 0.099 | 0.176 | 5 Hydroxytryptamine 7 agonist | 0.176 0.004 CID_124087 | CID_124087 | |
| 0.033 | 0.096 | 0.126 | CXC chemokine 4 receptor antagonist | 0.126 0.019 CID_124087 | CID_124087 | |
| 0.046 | 0.111 | 0.065 | Phosphodiesterase 1C inhibitor | 0.065 0.037 CID_124087 | CID_124087 | |
| 0.031 | 0.096 | 0.075 | Alpha 1 adrenoreceptor agonist | 0.075 0.025 CID_124087 | CID_124087 | |
| 0.113 | 0.18 | 0.196 | Potassium channel blocker | 0.196 0.095 CID_124087 | CID_124087 | |
| 0.032 | 0.103 | 0.2 | 5 Hydroxytryptamine 2A agonist | 0.2 0.004 CID_124087 | CID_124087 | |
| 0.033 | 0.104 | 0.089 | Alpha 1b adrenoreceptor antagonist | 0.089 0.04 CID_124087 | CID_124087 | |
| 0.05 | 0.121 | 0.066 | Exportin-1 inhibitor | 0.066 0.053 CID_124087 | CID_124087 | |
| 0.023 | 0.095 | 0.067 | Alpha 1d adrenoreceptor antagonist | 0.067 0.036 CID_124087 | CID_124087 | |
| 0.026 | 0.098 | 0.045 | Glutamate (mGluR5) agonist | 0.045 0.033 CID_124087 | CID_124087 | |
| 0.17 | 0.244 | 0.206 | Toll-Like receptor 7 agonist | 0.206 0.194 CID_124087 | CID_124087 | |
| 0.021 | 0.094 | 0.08 | AMPA receptor antagonist | 0.08 0.017 CID_124087 | CID_124087 | |
| 0.05 | 0.125 | 0.131 | NMDA receptor antagonist | 0.131 0.031 CID_124087 | CID_124087 | |
| 0.055 | 0.131 | 0.079 | GABA A receptor agonist | 0.079 0.064 CID_124087 | CID_124087 | |
| 0.157 | 0.234 | 0.217 | Tyrosine 3 hydroxylase inhibitor | 0.217 0.107 CID_124087 | CID_124087 | |
| 0.041 | 0.119 | 0.093 | Corticotropin releasing factor 2 receptor antagonist | 0.093 0.009 CID_124087 | CID_124087 | |
| 0.054 | 0.137 | 0.094 | MAP kinase kinase kinase inhibitor | 0.094 0.072 CID_124087 | CID_124087 | |
| 0.036 | 0.122 | 0.057 | Phosphodiesterase 1B inhibitor | 0.057 0.047 CID_124087 | CID_124087 | |
| 0.062 | 0.15 | 0.097 | Nitric-oxide synthase inhibitor | 0.097 0.064 CID_124087 | CID_124087 | |
| 0.074 | 0.162 | 0.176 | Sodium channel (voltage-gated) blocker | 0.176 0.039 CID_124087 | CID_124087 | |
| 0.033 | 0.125 | 0.12 | Adrenaline uptake inhibitor | 0.12 0.014 CID_124087 | CID_124087 | |
| 0.017 | 0.111 | 0.043 | Glutamate (mGluR group I) agonist | 0.043 0.039 CID_124087 | CID_124087 | |
| 0.064 | 0.158 | 0.17 | MAP kinase 12 inhibitor | 0.17 0.032 CID_124087 | CID_124087 | |
| 0.017 | 0.112 | 0.037 | Poly(ADP-ribose) polymerase 1 inhibitor | 0.037 0.026 CID_124087 | CID_124087 | |
| 0.064 | 0.16 | 0.222 | GABA C receptor antagonist | 0.222 0.009 CID_124087 | CID_124087 | |
| 0.091 | 0.186 | 0.205 | Cyclin-dependent kinase 8 inhibitor | 0.205 0.032 CID_124087 | CID_124087 | |
| 0.109 | 0.206 | 0.151 | ATPase inhibitor | 0.151 0.1 CID_124087 | CID_124087 | |
| 0.1 | 0.197 | 0.148 | Tumour necrosis factor antagonist | 0.148 0.104 CID_124087 | CID_124087 | |
| 0.022 | 0.122 | 0.047 | Poly(ADP-ribose) polymerase inhibitor | 0.047 0.027 CID_124087 | CID_124087 | |
| 0.031 | 0.131 | 0.094 | Protein kinase C iota inhibitor | 0.094 0.02 CID_124087 | CID_124087 | |
| 0.075 | 0.177 | 0.286 | Protein kinase C nu inhibitor | 0.286 0.027 CID_124087 | CID_124087 | |
| 0.059 | 0.165 | 0.157 | MAP kinase 13 inhibitor | 0.157 0.033 CID_124087 | CID_124087 | |
| 0.022 | 0.132 | 0.075 | Protein kinase C epsilon inhibitor | 0.075 0.022 CID_124087 | CID_124087 | |
| 0.05 | 0.16 | 0.129 | Protein kinase C delta inhibitor | 0.129 0.031 CID_124087 | CID_124087 | |
| 0.041 | 0.152 | 0.1 | Acetylcholine nicotinic agonist | 0.1 0.037 CID_124087 | CID_124087 | |
| 0.042 | 0.158 | 0.063 | Transforming growth factor antagonist | 0.063 0.061 CID_124087 | CID_124087 | |
| 0.033 | 0.151 | 0.081 | Nav1.7 sodium channel blocker | 0.081 0.033 CID_124087 | CID_124087 | |
| 0.024 | 0.143 | 0.047 | Transforming growth factor beta 1 antagonist | 0.047 0.037 CID_124087 | CID_124087 | |
| 0.036 | 0.156 | 0.087 | Protein kinase B beta inhibitor | 0.087 0.035 CID_124087 | CID_124087 | |
| 0.065 | 0.186 | 0.142 | Activin receptor-like kinase 4 inhibitor | 0.142 0.033 CID_124087 | CID_124087 | |
| 0.024 | 0.145 | 0.061 | Nicotinic receptor alpha4 subunit antagonist | 0.061 0.021 CID_124087 | CID_124087 | |
| 0.019 | 0.14 | 0.114 | 5 Hydroxytryptamine uptake inhibitor | 0.114 0.022 CID_124087 | CID_124087 | |
| 0.022 | 0.143 | 0.058 | Nicotinic neuronal receptor agonist | 0.058 0.037 CID_124087 | CID_124087 | |
| 0.024 | 0.146 | 0.075 | Histamine agonist | 0.075 0.016 CID_124087 | CID_124087 | |
| 0.024 | 0.146 | 0.056 | Dopamine uptake inhibitor | 0.056 0.042 CID_124087 | CID_124087 | |
| 0.019 | 0.153 | 0.04 | Nicotinic receptor alpha3 subunit antagonist | 0.04 0.035 CID_124087 | CID_124087 | |
| 0.031 | 0.168 | 0.085 | Rho-associated kinase I inhibitor | 0.085 0.042 CID_124087 | CID_124087 | |
| 0.023 | 0.16 | 0.076 | Potassium channel small-conductance Ca-activated blocker | 0.076 0.011 CID_124087 | CID_124087 | |
| 0.084 | 0.221 | 0.142 | Neuropeptide Y1 antagonist | 0.142 0.077 CID_124087 | CID_124087 | |
| 0.094 | 0.233 | 0.174 | MAP kinase 3 inhibitor | 0.174 0.039 CID_124087 | CID_124087 | |
| 0.1 | 0.242 | 0.158 | MAP kinase kinase 4 inhibitor | 0.158 0.048 CID_124087 | CID_124087 | |
| 0.045 | 0.188 | 0.095 | HIV-1 integrase (Overall Integration) inhibitor | 0.095 0.059 CID_124087 | CID_124087 | |
| 0.025 | 0.168 | 0.082 | Neuronal nicotinic receptor antagonist | 0.082 0.035 CID_124087 | CID_124087 | |
| 0.018 | 0.162 | 0.041 | Nerve growth factor antagonist | 0.041 0.032 CID_124087 | CID_124087 | |
| 0.092 | 0.239 | 0.143 | Non-steroidal antiinflammatory agent | 0.143 0.126 CID_124087 | CID_124087 | |
| 0.174 | 0.325 | 0.339 | MAP kinase kinase 6 inhibitor | 0.339 0.101 CID_124087 | CID_124087 | |
| 0.08 | 0.238 | 0.161 | Polo-like kinase-3 inhibitor | 0.161 0.073 CID_124087 | CID_124087 | |
| 0.029 | 0.189 | 0.09 | Acetylcholine nicotinic antagonist | 0.09 0.046 CID_124087 | CID_124087 | |
| 0.006 | 0.166 | 0.044 | Imidazoline I1 receptor antagonist | 0.044 0.004 CID_124087 | CID_124087 | |
| 0.014 | 0.175 | 0.081 | NMDA 2C receptor antagonist | 0.081 0.025 CID_124087 | CID_124087 | |
| 0.05 | 0.212 | 0.133 | Nav1.3 sodium channel blocker | 0.133 0.061 CID_124087 | CID_124087 | |
| 0.042 | 0.206 | 0.166 | Protein kinase C mu inhibitor | 0.166 0.02 CID_124087 | CID_124087 | |
| 0.034 | 0.201 | 0.075 | Protein kinase B gamma inhibitor | 0.075 0.052 CID_124087 | CID_124087 | |
| 0.024 | 0.196 | 0.129 | Check point kinase 1 inhibitor | 0.129 0.018 CID_124087 | CID_124087 | |
| 0.019 | 0.191 | 0.049 | Nicotinic receptor alpha7 subunit antagonist | 0.049 0.048 CID_124087 | CID_124087 | |
| 0.157 | 0.331 | 0.259 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.259 0.055 CID_124087 | CID_124087 | |
| 0.047 | 0.225 | 0.162 | Protein kinase C zeta inhibitor | 0.162 0.017 CID_124087 | CID_124087 | |
| 0.104 | 0.286 | 0.149 | Cyclin-dependent kinase 3 inhibitor | 0.149 0.097 CID_124087 | CID_124087 | |
| 0.082 | 0.266 | 0.23 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.23 0.063 CID_124087 | CID_124087 | |
| 0.042 | 0.227 | 0.095 | Insulin receptor antagonist | 0.095 0.069 CID_124087 | CID_124087 | |
| 0.029 | 0.217 | 0.142 | Protein kinase A inhibitor | 0.142 0.027 CID_124087 | CID_124087 | |
| 0.052 | 0.24 | 0.196 | Ca2+/calmodulin-dependent kinase II delta inhibitor | 0.196 0.047 CID_124087 | CID_124087 | |
| 0.02 | 0.212 | 0.076 | MAP kinase 11 inhibitor | 0.076 0.051 CID_124087 | CID_124087 | |
| 0.077 | 0.272 | 0.134 | Adenylate cyclase stimulant | 0.134 0.094 CID_124087 | CID_124087 | |
| 0.029 | 0.224 | 0.067 | Protein kinase B alpha inhibitor | 0.067 0.05 CID_124087 | CID_124087 | |
| 0.065 | 0.262 | 0.161 | Protein kinase (CK1) gamma 3 inhibitor | 0.161 0.078 CID_124087 | CID_124087 | |
| 0.033 | 0.236 | 0.075 | I kappa B kinase 1 inhibitor | 0.075 0.041 CID_124087 | CID_124087 | |
| 0.021 | 0.225 | 0.135 | Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor | 0.135 0.023 CID_124087 | CID_124087 | |
| 0.025 | 0.23 | 0.07 | Phospholipase D inhibitor | 0.07 0.054 CID_124087 | CID_124087 | |
| 0.03 | 0.239 | 0.076 | Glycine receptor antagonist | 0.076 0.063 CID_124087 | CID_124087 | |
| 0.027 | 0.238 | 0.061 | Heat shock protein 90 beta antagonist | 0.061 0.038 CID_124087 | CID_124087 | |
| 0.019 | 0.233 | 0.078 | Protein kinase C beta inhibitor | 0.078 0.034 CID_124087 | CID_124087 | |
| 0.044 | 0.262 | 0.154 | CDC-like kinase 2 inhibitor | 0.154 0.09 CID_124087 | CID_124087 | |
| 0.015 | 0.234 | 0.034 | Protein kinase (CK2) beta inhibitor | 0.034 0.021 CID_124087 | CID_124087 | |
| 0.023 | 0.242 | 0.062 | Botulinum neurotoxin type A inhibitor | 0.062 0.035 CID_124087 | CID_124087 | |
| 0.054 | 0.273 | 0.119 | Nav1.2 sodium channel blocker | 0.119 0.084 CID_124087 | CID_124087 | |
| 0.049 | 0.273 | 0.221 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.221 0.062 CID_124087 | CID_124087 | |
| 0.05 | 0.275 | 0.087 | Alpha 2d adrenoreceptor antagonist | 0.087 0.08 CID_124087 | CID_124087 | |
| 0.093 | 0.32 | 0.221 | Superoxide dismutase inhibitor | 0.221 0.096 CID_124087 | CID_124087 | |
| 0.061 | 0.288 | 0.138 | Aurora-C kinase inhibitor | 0.138 0.068 CID_124087 | CID_124087 | |
| 0.183 | 0.417 | 0.348 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.348 0.153 CID_124087 | CID_124087 | |
| 0.021 | 0.259 | 0.089 | CYP2A6 inhibitor | 0.089 0.042 CID_124087 | CID_124087 | |
| 0.021 | 0.271 | 0.071 | I kappa B kinase 2 inhibitor | 0.071 0.031 CID_124087 | CID_124087 | |
| 0.004 | 0.256 | 0.017 | Histamine H4 receptor agonist | 0.017 0.015 CID_124087 | CID_124087 | |
| 0.003 | 0.264 | 0.017 | Alpha 2a adrenoreceptor agonist | 0.017 0.013 CID_124087 | CID_124087 | |
| 0.045 | 0.312 | 0.125 | Protein kinase (CK1) gamma 1 inhibitor | 0.125 0.092 CID_124087 | CID_124087 | |
| 0.025 | 0.295 | 0.104 | I kappa B kinase inhibitor | 0.104 0.035 CID_124087 | CID_124087 | |
| 0.01 | 0.287 | 0.047 | Toll-Like receptor 8 antagonist | 0.047 0.045 CID_124087 | CID_124087 | |
| 0.008 | 0.286 | 0.052 | Dopamine D5 agonist | 0.052 0.016 CID_124087 | CID_124087 | |
| 0.108 | 0.392 | 0.169 | Nitric-oxide synthase stimulant | 0.169 0.155 CID_124087 | CID_124087 | |
| 0.054 | 0.344 | 0.196 | Death-associated protein kinase 3 inhibitor | 0.196 0.077 CID_124087 | CID_124087 | |
| 0.016 | 0.322 | 0.097 | Protein kinase (CK2) inhibitor | 0.097 0.067 CID_124087 | CID_124087 | |
| 0.007 | 0.313 | 0.048 | Alpha 1d adrenoreceptor agonist | 0.048 0.018 CID_124087 | CID_124087 | |
| 0.067 | 0.378 | 0.209 | Focal adhesion kinase 2 inhibitor | 0.209 0.063 CID_124087 | CID_124087 | |
| 0.029 | 0.344 | 0.135 | 5 Hydroxytryptamine 3A agonist | 0.135 0.045 CID_124087 | CID_124087 | |
| 0.015 | 0.333 | 0.101 | Protein kinase (CK2) alpha inhibitor | 0.101 0.075 CID_124087 | CID_124087 | |
| 0.044 | 0.363 | 0.12 | Heat shock protein 90 antagonist | 0.12 0.113 CID_124087 | CID_124087 | |
| 0.011 | 0.333 | 0.058 | Pim-2 kinase inhibitor | 0.058 0.033 CID_124087 | CID_124087 | |
| 0.043 | 0.368 | 0.13 | Heat shock protein 90 alpha antagonist | 0.13 0.111 CID_124087 | CID_124087 | |
| 0.019 | 0.349 | 0.097 | Pim-3 kinase inhibitor | 0.097 0.049 CID_124087 | CID_124087 | |
| 0.033 | 0.365 | 0.09 | Electrolyte absorption antagonist | 0.09 0.075 CID_124087 | CID_124087 | |
| 0.023 | 0.355 | 0.102 | Polo-like kinase-4 inhibitor | 0.102 0.075 CID_124087 | CID_124087 | |
| 0.032 | 0.373 | 0.159 | Dyrk kinase inhibitor | 0.159 0.128 CID_124087 | CID_124087 | |
| 0.013 | 0.356 | 0.089 | Check point kinase 2 inhibitor | 0.089 0.075 CID_124087 | CID_124087 | |
| 0.003 | 0.348 | 0.028 | Endothelial nitric-oxide synthase inhibitor | 0.028 0.025 CID_124087 | CID_124087 | |
| 0.025 | 0.37 | 0.118 | Toll-Like receptor 9 antagonist | 0.118 0.088 CID_124087 | CID_124087 | |
| 0.027 | 0.381 | 0.127 | Ribosomal protein S6 kinase inhibitor | 0.127 0.084 CID_124087 | CID_124087 | |
| 0.015 | 0.382 | 0.1 | Pim-1 kinase inhibitor | 0.1 0.058 CID_124087 | CID_124087 | |
| 0.024 | 0.405 | 0.145 | LIM domain kinase 1 inhibitor | 0.145 0.103 CID_124087 | CID_124087 | |
| 0.018 | 0.408 | 0.109 | Protein kinase (CK1) gamma inhibitor | 0.109 0.104 CID_124087 | CID_124087 | |
| 0.107 | 0.498 | 0.271 | 5 Hydroxytryptamine uptake stimulant | 0.271 0.063 CID_124087 | CID_124087 | |
| 0.012 | 0.411 | 0.064 | Myc inhibitor | 0.064 0.024 CID_124087 | CID_124087 | |
| 0.027 | 0.428 | 0.195 | MAP kinase kinase 2 inhibitor | 0.195 0.085 CID_124087 | CID_124087 | |
| 0.028 | 0.43 | 0.162 | I kappa B kinase epsilon inhibitor | 0.162 0.107 CID_124087 | CID_124087 | |
| 0.019 | 0.427 | 0.129 | Vascular endothelial growth factor 3 antagonist | 0.129 0.086 CID_124087 | CID_124087 | |
| 0.065 | 0.486 | 0.155 | Death-associated protein kinase 2 inhibitor | 0.155 0.095 CID_124087 | CID_124087 | |
| 0.014 | 0.571 | 0.112 | GABA C receptor agonist | 0.112 0.055 CID_124087 | CID_124087 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |